Daniel Nadis

Chief Executive Officer @Occams Resources

New Haven, CT, US
EMAILS
d••••••••@anthogen.com
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2014 — Present

Chief Executive Officer @Occams Resources

View department →

EDUCATION

1970 — 1973

Residential College, University of Michigan

Bachelor of Arts (B.A.), History

1970 — 1972

The Hebrew University of Jerusalem

Bachelor's degree, European History

1973 — 1974

University of Michigan

Rackham School of Graduate Studies, University of Michigan, 20th Century Middle East History, Magna cum laude

1974 — 1977

University of Michigan Law School

Juris Doctor, Law

ABOUT DANIEL NADIS

Serial entrepreneur focused on medical device sales and finance. Current Portfolio includes digital health device companies providing actionable real-time diagnostic information as well as addressing multi-billion dollar markets. INTERNATIONAL TECHNOLOGY MANAGEMENT AND FINANCE General Management – Business Leadership - current. • Chairman, Access for Life – Kidney Dialysis device technology • Global Advisor – Sales and Marketing, ATLASense Biomed, Ltd. • North America Advisor – Sales – Medivizor • CEO – Occams Resources (Algorithms for Medical Sensors) General Management – Business Leadership - previous. • CEO Directed Connections – Europe and N. Am. Sale Finance programs for Med device companies including Toshiba, Philips, Thermo-Fisher, 40 others. • CEO – QM Bio – Bio incubator (London) • CEO – GE Capital [Equipment Finance] Europe Management Consulting experience: Market assessment for products ranging from medical diagnostics to biopharma to medical devices – over 20 companies served. Advisor to largest pathology lab in Israel in outsource analytic services to NHS (UK). Corporate Transactions • Acquired, managed and sold No. 3 (US) test equipment rental firm for 180% return in one year. • Set up, raised capital ($60M), built and opened largest Bio-Incubator in London for QM Bio. • Started up, managed and sold AI-driven on line sales platform company serving medical device market. Client Funding: Raised equity from Family Offices/VCs for both UK and US companies. Gained government grants for European, Israeli and US companies. Publications: Co-author of paper defining algorithm-driven assessment of biology research protocols. Frequent lecturer on how to serve the healthcare customer in different funding regimes.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.